CAC 40 Gains Amid Earnings Deluge

RTTNews | 10 days ago
CAC 40 Gains Amid Earnings Deluge

(RTTNews) - French stocks rose on Friday, though overall gains remained capped ahead of the release of the Federal Reserve's preferred inflation measure due later in the day.

Meanwhile, France's consumer confidence unexpectedly decreased in April, monthly survey data from the statistical office INSEE showed earlier today. The consumer sentiment index dropped to 90 in April from 91 in the previous month. Economists had expected the score to rise to 92.

The benchmark CAC 40 was up 28 points, or 0.4 percent, at 8,045 after declining 0.9 percent the previous day.

In corporate news, energy giant TotalEnergies edged up slightly after reporting a smaller-than-expected drop in first-quarter profit.

Construction materials group Saint-Gobain surged nearly 6 percent after Q1 revenue topped forecasts.

Planemaker Airbus fell 2.3 percent after posting weaker-than-expected first-quarter operating profit and cashflow.

Construction and infrastructure company Vinci rose 1.3 percent after confirming its forecasts for the year.

Aerospace-industry supplier Safran declined 1.3 percent despite posting higher Q1 revenue and reaffirming its FY24 outlook.

read more
Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Financial services company Cohen & Co. Inc. (COHN) reported Monday net income attributable to Company for the first quarter of $2.02 million or $1.28 per share, compared to a net loss of $2.64 million or $1.77 per share in the prior-year quarter.
RTTNews | 4h 19min ago
Eurozone Private Sector Growth Accelerates In April

Eurozone Private Sector Growth Accelerates In April

The euro area private sector growth accelerated to an 11-month high in April driven by the service sector, final survey results from S&P Global showed on Monday. The HCOB composite output index rose to 51.7 in April from 50.3 in the previous month. The flash estimate was 51.4.
RTTNews | 4h 29min ago
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews | 4h 50min ago
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews | 5h 30min ago
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews | 5h 34min ago
BioNTech Slips To Loss In Q1

BioNTech Slips To Loss In Q1

Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews | 6h 36min ago